Macquarie Group
PRCT icon

Macquarie Group’s Procept Biorobotics PRCT Stock Holding History

Macquarie Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-190,923
Closed -$6.81M – 1332
2025
Q3 		$6.81M Buy
190,923
+52,671
+38% +$2.4M 0.01% 889
2025
Q2 		$7.96M Buy
138,252
+57,183
+71% +$3.23M 0.01% 865
2025
Q1 		$4.72M Sell
81,069
-146,462
-64% -$10M 0.01% 994
2024
Q4 		$18.3M Buy
227,531
+18,662
+9% +$1.59M 0.02% 668
2024
Q3 		$16.7M Buy
+208,869
New +$14.8M 0.02% 717

Other funds holding PRCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Macquarie Group's PRCT Position: Q4 2025 in Review

Macquarie Group sold out of Procept Biorobotics (PRCT) in Q4 2025, closing a stake of 190,923 shares — an estimated $6.81M sold.

Macquarie Group first reported a position in PRCT in Q3 2024 and held it in 5 quarters. The position peaked at $18.3M in Q4 2024. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • Macquarie Group reported no remaining Procept Biorobotics position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 190,923 Procept Biorobotics shares in Q4 2025, an estimated $6.81M.
  • Macquarie Group first reported a position in Procept Biorobotics in Q3 2024 and held it in 5 quarters.
  • Macquarie Group's Procept Biorobotics position peaked at $18.3M in Q4 2024.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.